2.73
price up icon6.23%   0.16
after-market Handel nachbörslich: 2.73
loading
Schlusskurs vom Vortag:
$2.57
Offen:
$2.61
24-Stunden-Volumen:
629.03K
Relative Volume:
1.02
Marktkapitalisierung:
$280.97M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-8.0294
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
+3.02%
1M Leistung:
-11.65%
6M Leistung:
-28.91%
1J Leistung:
-31.06%
1-Tages-Spanne:
Value
$2.61
$2.84
1-Wochen-Bereich:
Value
$2.50
$2.84
52-Wochen-Spanne:
Value
$2.21
$5.26

Maxcyte Inc Stock (MXCT) Company Profile

Name
Firmenname
Maxcyte Inc
Name
Telefon
301-517-5556
Name
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
MXCT's Discussions on Twitter

Vergleichen Sie MXCT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
MXCT
Maxcyte Inc
2.73 280.97M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-29 Eingeleitet Craig Hallum Buy
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-24 Eingeleitet BTIG Research Buy
2021-08-24 Eingeleitet Cowen Outperform
2021-08-24 Eingeleitet Stephens Overweight
2021-08-24 Eingeleitet Stifel Buy
2021-08-24 Eingeleitet Wedbush Outperform
2021-08-24 Eingeleitet William Blair Outperform
Alle ansehen

Maxcyte Inc Aktie (MXCT) Neueste Nachrichten

pulisher
09:48 AM

BlackRock Adjusts Stake in MaxCyte, Inc. - TipRanks

09:48 AM
pulisher
09:44 AM

MaxCyte Announces Change in Major Shareholder Holdings - TipRanks

09:44 AM
pulisher
Apr 16, 2025

Vanguard Group Inc. Sells 345,587 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Cooley Advises Cell Therapy Biz On London Market Exit - Law360

Apr 15, 2025
pulisher
Apr 15, 2025

MaxCyte intends to delist from London's AIM to enhance liquidity - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

MaxCyte to Delist from AIM, Focus on Nasdaq - TipRanks

Apr 15, 2025
pulisher
Apr 14, 2025

MaxCyte Announces Change in Voting Rights Structure - TipRanks

Apr 14, 2025
pulisher
Apr 10, 2025

MaxCyte stock plunges to 52-week low of $2.25 amid market challenges By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte stock plunges to 52-week low of $2.25 amid market challenges - Investing.com India

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte sets date for Q1 2025 financial results reveal By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte sets date for Q1 2025 financial results reveal - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte to Announce Q1 2025 Financial Results - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Insider Buyers Lose US$201k As MaxCyte Sheds UK£32m - simplywall.st

Apr 10, 2025
pulisher
Apr 08, 2025

Down -27.78% in 4 Weeks, Here's Why You Should You Buy the Dip in MaxCyte (MXCT) - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

With 66% institutional ownership, MaxCyte, Inc. (LON:MXCT) is a favorite amongst the big guns - Yahoo Finance

Apr 08, 2025
pulisher
Apr 07, 2025

Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround - Yahoo Finance

Apr 07, 2025
pulisher
Apr 06, 2025

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN

Apr 06, 2025
pulisher
Apr 05, 2025

MaxCyte Inc (MXCT) Volatility Hits 6.24% – Here Is What You Should Do - Stocksregister

Apr 05, 2025
pulisher
Apr 03, 2025

MaxCyte Stock Hits 52-Week Low at $2.62 Amid Market Challenges - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

MaxCyte Stock Hits 52-Week Low at $2.62 Amid Market Challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 01, 2025

MaxCyte Expands Capital with New Stock Issuance - TipRanks

Apr 01, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Decreases Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

MaxCyte stock plunges to 52-week low, touches $2.75 - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

MaxCyte stock plunges to 52-week low, touches $2.75 By Investing.com - Investing.com UK

Mar 27, 2025
pulisher
Mar 26, 2025

MaxCyte CFO completes RSU vesting and tax-related sale By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

MaxCyte CFO completes RSU vesting and tax-related sale - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

MaxCyte Announces CFO’s RSU Vesting and Share Sale - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Reduces Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

MaxCyte executives receive equity incentives By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

MaxCyte executives receive equity incentives - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

MaxCyte Awards Stock Options and Units to Executives - TipRanks

Mar 24, 2025
pulisher
Mar 21, 2025

Maxcyte CFO Douglas Swirsky sells $22,061 in common stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 20, 2025

MaxCyte chief commercial officer Ali Soleymannezhad sells $3,850 in stock By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

MaxCyte chief commercial officer Ali Soleymannezhad sells $3,850 in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Maxcyte general counsel David Sandoval sells $1,122 in stock - Investing.com

Mar 20, 2025

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Kapitalisierung:     |  Volumen (24h):